Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015002 · ClinicalTrials.gov registry record · Phase 3
Repeat Antenatal Steroids Trial
A Phase 3 study, sponsored by The George Washington University Biostatistics Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 486
- Enrollment target
NCT00015002 is a Phase 3 study that was terminated before completion, run by The George Washington University Biostatistics Center. The registered enrollment target is 486 participants.
The verdict
NCT00015002, a Phase 3 study, was terminated before completion, sponsored by The George Washington University Biostatistics Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 486 participants
- Enrollment target
Study Summary
A course of steroids given to a mother who is in labor with a premature fetus will reduce the risk of the premature infant dying or having serious complications. This trial will test whether more than one course of antenatal steroids is more beneficial or risky to the infant than a single course.
Interventions
- DRUG Betamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 486 participants |
| Start Date | 2000-03 |
| Est. Completion | 2007-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00015002
The ClinicalTrials.gov registry entry for NCT00015002 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 486 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The George Washington University Biostatistics Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Betamethasone is the first listed.
NCT00015002 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00015002 about?
NCT00015002 is a clinical study titled "Repeat Antenatal Steroids Trial". A course of steroids given to a mother who is in labor with a premature fetus will reduce the risk of the premature infant dying or having serious complications. This trial will test whether more than one course of antenatal steroids is more beneficial or risky to the infant than a single course.
What is the current status of trial NCT00015002?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 486 participants. The study started on 2000-03. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00015002?
The interventions under investigation include: Betamethasone (DRUG).
Who is sponsoring clinical trial NCT00015002?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.